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Objective: To assess the potential protective effects of three polyphenols oleuropein, rutin and curcumin,
on joint ageing and osteoarthritis (OA) development.
Design: Sixty 4-week-old DunkineHartley guinea pigs were randomized into four groups and received
daily during 31 weeks either standard guinea pig diet (control group) or a standard guinea pig diet
enriched with oleuropein (0.025%), rutin (0.5%) or rutin/curcumin (0.5%/0.25%) association. Biomarkers
of OA (Coll2-1, Coll2-1NO2, Fib3-1, Fib3-2, ARGS), as well as inﬂammation prostaglandin E2 (PGE2) were
quantiﬁed in the serum. Histological assessments of knee cartilage and synovial membrane were per-
formed at week 4 (ﬁve young reference guinea pigs) and week 35.
Results: Atweek 35, guinea pigs in the control group spontaneously developed signiﬁcant cartilage lesions
with mild synovial inﬂammation. The histological scores of cartilage lesions and synovitis were well
correlatedwith the increased level of serumbiomarkers. Histologically, all treatments signiﬁcantly reduced
the cartilage degradation score (P < 0.01), but only oleuropein signiﬁcantly decreased the synovial histo-
logical score (P < 0.05) and serum PGE2 levels (P < 0.01) compared to the control group. Coll2-1 was
decreased by rutin and the combination of rutin/curcumin, Fib3-1 and Fib3-2 were only decreased by the
rutin/curcumin mixture, while Coll2-1NO2 was signiﬁcantly decreased by all treatments (P < 0.05).
Conclusion: Oleuropein and rutin ± curcumin signiﬁcantly slowed down the progression of spontaneous
OA lesions in guinea pigs. While no additive effect was seen in the curcumin þ rutin group, the differ-
ential effects of oleuropein and rutin on inﬂammatory and cartilage catabolic markers suggest an
interesting combination for future studies in OA protection.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Y. Henrotin, Bone and Carti-
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Osteoarthritis (OA) is a high prevalence disease with an
important socio-economic impact. OA is characterized by ﬁbril-
lations, ﬁssures, and even in late stage of the disease, disap-
pearance of cartilage. Furthermore, cartilage degradation is
associated with structural and metabolic changes in other joint
tissues such as subchondral bone sclerosis and synovial mem-
brane inﬂammation1. Numerous models have been proposed to
investigate the natural course of the disease and to study the
effects of treatments. Among these models, DunkineHartley
guinea pigs developing spontaneous OA is very attractive becausetd. All rights reserved.
Table I
Composition of the experimental diets
Control in (%) Oleuropein (%) Rutin (%) Rutin þ
curcumin (%)
Corn starch* 46.4 46.38 45.9 45.65
Soy proteiny 18.7 18.7 18.7 18.7
DL-methioninez 1.0 1.0 1.0 1.0
Sucrosex 5.0 5.0 5.0 5.0
Cellulosek 10.0 10.0 10.0 10.0
Guar gumz 2.5 2.5 2.5 2.5
Mineral mix¶ 7.5 7.5 7.5 7.5
Vitamin mix¶ 1.0 1.0 1.0 1.0
Choline bitartratez 0.5 0.5 0.5 0.5
Ascorbic acidz 0.4 0.4 0.4 0.4
Kliba diet 3420# 3.0 3.0 3.0 3.0
Palm oilz 0.8 0.8 0.8 0.8
Soybean oil** 3.04 3.04 3.04 3.04
Linseed oilz 0.16 0.16 0.16 0.16
Oleuropeinyy 0 0.025 0 0
Rutinz 0 0 0.5 0.5
Curcuminz 0 0 0 0.25
yy Extrasynthese, Genay, France.
* Schweizerhall Chemie, Basel, Switzerland.
y Solae, Grand-Saconnex, Switzerland.
z Sigma Aldrich, Buchs, Switzerland.
x Howeg, Aaberg, Switzerland.
k Christ Water Technology Group, Basel, Switzerland.
¶ Vital AG, Oberentfelden, Switzerland according to mineral (no250001) and
vitamin (no 350001) mix composition from Dyets, Inc., Bethlehem, PA.
# Provimi Kliba AG, Kaiseraugst, Switzerland.
** Florin, Muttenz, Switzerland.
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primary human OA2.
The appearance of joint pathology in both guinea pigs and
humans is age-related and subject to a variety of well-recognized
OA risk factors including body weight, ligament laxity and high
bone turnover. Spontaneous lesions in the knee are bilateral and are
more pronounced in the medial compartment in the area not
covered by the meniscus. Bone cysts (2e3 months old), sub-
chondral bone thickening and osteophytes (3e12 months old) are
preceded by type II collagen ﬁbril disruption (2 months old)3, his-
tological proteoglycan loss (4e6 months old) and cartilage ﬁbril-
lations (8e12 months old)2,4e7. The involvement of interleukin (IL)-
1b and matrix metalloproteinases (MMP-3 and-13) in this degen-
erative process has been shown8.
Some epidemiological studies have reported an association be-
tween long-term consumption of diets rich in polyphenols and
protection against chronic diseases9 but few studies have investi-
gated the effects of such compounds on cartilage and no long-term
studies on OA have been carried out with phytonutrients10,11.
Nevertheless, antioxidant and anti-inﬂammatory properties of
polyphenols make them interesting candidates to study their po-
tential protective effect on cartilage. Recently, data from clinical
studies suggest that curcumin improved joint function, reduced
pain and type II collagen degradation in OA patients12,13.
The leaves and fruit of the olive plant (Olea europaea L.) are rich
in polyphenols exhibiting a range of beneﬁcial effects including
antioxidant, anti-inﬂammatory, antiatherogenic and anticarcino-
genic properties14, the most bioactive ones being oleuropein and
hydroxytyrosol. It has recently been demonstrated that oleuropein
protects against collagen II-induced arthritis in mice15. Rutin
(quercetin-3-O-rutinoside) is a ﬂavonoid ubiquitously found in
plants. Quercetin, the circulating aglycone form of rutin, is
considered to be a strong antioxidant due to its ability to scavenge
free radicals16,17.
The aim of the current study was to investigate if these poly-
phenols would exert a protective effect on cartilage and inﬂuence
the natural course of spontaneous OA in DunkineHartley guinea
pigs. Primary outcome was the improvement of global OA histo-
logical score, and secondary outcomes were the variation of serum
levels of biomarkers prostaglandin E2, ﬁbulin-3 fragments (Fib3-1
and Fib3-2), collagen (Coll2-1 and Coll2-1NO2) and aggrecan
(ARGS) neoepitopes.
Methods
All experimental procedures and protocols used in this investi-
gationwere reviewed and approved by the Institutional Animal Care
and Use Ethics Committee of the University of Liege (Belgium),
reference 1207. The “Guide for the Care and Use of Laboratory Ani-
mals,” prepared by the Institute of Laboratory Animal Resources,
National Research Council, and published by the National Academy
Press, was followed carefully as well as European and local legisla-
tion. Sixty-ﬁve 3-week-old male DunkineHartley guinea pigs were
obtained from Charles River Laboratories (Paris, France). Identiﬁca-
tion was made by microchip. Animals were housed ﬁve per solid
bottom cages and fed with a standard guinea pig chow diet (Table I)
and water ad libitum. PVC pipes were added to the cages to improve
housing conditions andminimize stress. All animals allowed 10 days
for acclimatization to housing conditions prior to phytonutrient
administration. As young reference group, ﬁve guinea pigs were
sacriﬁced at 4-week-old. The 60 remaining male 4-week-old Hartley
guinea pigs were randomized into four groups: one receiving a diet
containing a standard chow diet (n ¼ 15, the control group) and the
other groups receiving either a standard chow diet enriched with
0.025% of oleuropein (n ¼ 15), or with 0.5% of rutin (n ¼ 15) or with0.5% of rutin and 0.25% of curcumin (n ¼ 15) until week 35 (Table I).
The daily dose consumed during 31 weeks corresponds approxi-
mately to an intake of 12.5 mg/kg body weight for oleuropein,
250 mg/kg for rutin (thus 125 mg total equivalent aglycon) and
125 mg/kg for curcumin. The number of animal per group was
choose according to the Osteoarthritis Research Society Interna-
tional (OARSI) recommendation18 to provide 80% power to detect a
signiﬁcant change in response to a hypothetical treatment capable of
achieving a 30% treatment difference compared to untreated ani-
mals, with statistical signiﬁcance of P ¼ 0.05.
Animals were weighed every week. Food intake was controlled
at weeks 9, -15, -21, -26 and -34.
Blood sampling
At week 4, -10, -16, -22 and -28, 500 ml of blood was collected at
the superﬁcial veins of the ears, in the morning, under ketamine
(32 mg/kg)/xylazine (3 mg/kg) subcutaneous anaesthesia.
At week 4 for the young reference group and at week 35 for the
other groups, 2 ml of blood was collected by intracardiac puncture,
under general anaesthesia (sodium pentobarbital 200 mg/kg,
intraperitonealy), just before dead.
Blood was then centrifuged at 2000 g for 5 min, and serum
stored at 80C until analysis.
Histology
At euthanasia (week 4 or 35), the right knee joint from each
animal was ﬁxed for 24 h in 4% buffered paraformaldehyde, fol-
lowed by decalciﬁcation in HCl acid (DC2, Labonord) for 4 h at 4C
before parafﬁn embedding. The right kidney and a piece of liver
were also ﬁxed in 4% buffered paraformaldehyde and parafﬁn
embedded.
Parafﬁn embedded right knees were cut with a microtome into
6 mm sections, in the central area not covered by meniscus
following the Cushin plane, as recommended by OARSI18. Three
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green and safranin-O, or toluidine blue. To establish the OA score,
each compartment of the section (tibial median, tibial lateral,
femoral median and femoral lateral) was scored by two blinded
trained experts following OARSI recommendations for guinea pig
(cartilage surface integrity 0e8, proteoglycan content 0e6, cellu-
larity 0e3, tidemark integrity 0e1 and osteophyte 0e3, with a
maximum of 21 per compartment). The mean of three sections
score were calculated for each knee. To assess the global OA score
(primary outcome), scores of each compartments were added,
giving a maximal score of 84. Lateral and medial synovial mem-
branes were also scored (synovial lining cells hyperplasia 0e2,
villous hyperplasia 0e3, degree of cellular inﬁltration by peri-
vascular lymphocytes and mononuclear cells 0e5) and the mean of
lateral and median membrane was calculated to assess the global
synovial score (maximum score of 10)18.
PGE2, ARGS, Coll2-1, Coll2-1NO2, Fib3-1 and Fib3-2 immunoassays
Prostaglandin E2 (PGE2) was measured using a competitive
ELISA kit (Arbor Assays, USA), in serum collected at sacriﬁce (week
4 in young animal controls or week 35 in the other animals).
Coll2-1, Coll2-1NO2, Fib3-1 and Fib3-2 were quantiﬁed in trip-
licate by competitive ELISA, and ARGS in triplicate in deglycosylated
samples using a sandwich immunoassay with ECL technology on a
Meso Scale Discovery (MSD) platform, derived from immunoassay
previously described19, in serum collected at veins of the ears at
week 4,-10,-16,-22,-28, and intracardiacaly at week 35 (Artialis SA,
Liege, Belgium).
Calculation and statistical analysis
Results are expressed as mean with 95% CI. Following a
normality test (KolmogoroveSmirnov test for biomarker kinetics
and D'Agostino and Pearson omnibus normality test), one-way
analysis of variance (one-way ANOVA) with Dunnett's post-test
were performed for histology and biomarkers between week 4
and 35 in the control group and between treated groups and the
control group at week 35 (GraphPad Prism 5.0), Pearson correla-
tions were performed (GraphPad Prism 5.0) between each pa-
rameters. For longitudinal analysis of the biomarkers, a mixed
model with an undeﬁned covariance structure was ﬁtted to the
data to test for differences between the treatment groups. The
covariates included in the model were the time and the interaction
with the treatment indicator. However, based on a graphical
investigation of the data, a quadratic time effect was considered for
variable Fib3-2, Coll2-1, and Coll2-1NO2. This statistical method
permits the comparison of response curves between treatments
while accounting for repeated data within each guinea pig. Calcu-
lations were always carried out on the maximum number of data
available. Results were considered to be signiﬁcant at the 5% critical
level (P < 0.05). Data analysis was carried out using SAS (version 9.3
for Windows) statistical package.
Results
Housing and weight evolution
At baseline (week 4), guinea pigs weighed 262 g (95% CI: 258,
266). The four groups gained weight in the same way during the
study. No difference of weight between groups was observed during
the study and food intake was similar in all groups. At the end of the
study (week 35), weight of the animals was 934 g (95% CI: 910, 964).
One guinea pig was excluded from the analysis in the control group
because its weight was only 620 g at week 35, clearly out of rangecomparing to the other animals. Six guinea pigs died during the
study, two in control group, two in oleuropein group and two in rutin
group. Data collected until their deaths were used for the analysis.
With the exception of one spontaneous death in rutin group at week
23, complications that led to other death/euthanasia were:
- peritoneal lesion after injection (one from oleuropein group at
week 10).
- incapacity for two guinea pigs to wake up (two from control
group at week 16).
- acutemyocardial infarction after handling (one from rutin group
at week 28).
- severe injuries after ﬁght with a fellow (one from oleuropein
group at week 31).Histology
As expected, guinea pigs spontaneously developed severe knee
OA (Fig. 1). In all animals, the global OA histological score increased
with age [P < 0.001 betweenweek 4 and 35, Fig. 2 (A)]. At week 35, a
signiﬁcant decrease of the global OA histological score was observed
in treated group compared to controls: 46 (95% CI: 41.4, 50.6) in
control vs 33.2 (95% CI: 29.9, 36.5) in oleuropein group (P< 0.001), vs
36.9 (95% CI; 32.9, 40.8) in rutin group (P < 0.01) and vs 36.7 (95% CI:
32.2, 41.1) in rutinþ curcumin (P < 0.01) group [Figs. 1 and 2(A)]. No
signiﬁcant difference between the treated groups was observed.
When femoral, tibial, medial or lateral compartments were analysed
individually, oleuropein and rutin decreased histological lesions
severity in each compartment. In contrast, rutinþ curcumin tended,
but didn't signiﬁcantly decrease the OA histological score in the
femoral compartment but was efﬁcient in the other compartments.
When histological items were analysed individually, all treatments
improved signiﬁcantly cartilage surface integrity [P < 0.01, Fig. 2(B)]
and increased proteoglycan content [P < 0.01, Fig. 2(C)]. Further-
more, cellularity score was signiﬁcantly lower in oleuropein and
rutin þ curcumin groups [P < 0.05, Fig. 2(D)], and osteophyte score
signiﬁcantly lower in oleuropein group compared to controls
[P < 0.05, Fig. 2(F)]. No treatment was able to modify the tidemark
integrity score [Fig. 2(E)].
A signiﬁcant increase of the synovial score between week 4 and
week 35 was observed in the control group [P < 0.01, Fig. 3(A)]. The
global synovial OA histological score are well correlated with the
global OA histological score (r ¼ 0.81, P < 0.001).
At week 35, only oleuropein signiﬁcantly decreased the global
synovial OA histological score 4 (95% CI; 3.2, 4.8) in control group vs
2.9 (95% CI: 2.1, 3.6) in oleuropein group [P < 0.05, Fig. 3(A)]. More
precisely, oleuropein decreased lining and inﬁltrated cells (P < 0.05),
but was ineffective on villous hyperplasia (data not shown).
Serum PGE2
From week 4 to 35, serum PGE2 levels signiﬁcantly increased in
the control group (2.3-fold, P < 0.001) and were positively corre-
lated with the global OA histological score (r ¼ 0.54, P < 0.05) and
the global synovial histology score (r ¼ 0.55, P < 0.05).
At week 35, serum PGE2 levels were decreased by 46% in the
oleuropein group compared to the control group [P < 0.01,
Fig. 3(B)]. In contrast, rutin and rutin þ curcumin didn't modify
PGE2 levels.
Serum Coll2-1 and Coll2-1NO2
An overall inverted-U shape (or concave) trajectory was found
for Coll2-1 and Coll2-1NO2. Serum Coll2-1 levels increased
Fig. 1. Representative pictures of medial compartment of right guinea pig knees of each group, at week 35. Control ¼ control group, Oleur ¼ Oleuropein group, Rut ¼ Rutin group,
Rut þ Cur ¼ Rutin þ curcumin group. Safranin-O/fast green/hematoxylin staining, 5 magniﬁcation.
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increase compared to week 4 in the control group, P < 0.001) and
decreased between week 28 and 35 [Fig. 4(A)]. At week 35, serum
Coll2-1 level was still 1.8-fold higher than at week 4 (P < 0.001).
Coll2-1 NO2 reached a maximum at week 28 (2-fold increase
compared to week 4 in the control group, P < 0.001) and tended to
decrease to week 35 [still 1.8-fold higher than at week 4, P < 0.001,
Fig. 4(B)]. At week 35, no signiﬁcant correlationwas found between
Coll2-1 serum levels and the global histological OA or synovial
scores. However, a signiﬁcant and positive correlation was found
between the change of Coll2-1 between week 4 and 10 and the
global histological OA score at week 35 in all animals (r ¼ 0.32,
P < 0.05). A strong correlationwas found at week 35 between Coll2-
1NO2 levels and global OA score in the control group (r ¼ 0.77,
P < 0.001), and with the synovial score (r¼ 0.56, P < 0.05) as well as
between the evolution of Coll2-1NO2 between week 4 and 10 and
the ﬁnal histological OA score at week 35 in all animals (r ¼ 0.43,
P < 0.01). The Coll2-1NO2 levels quantiﬁed at week 10 (r ¼ 0.46,
P < 0.001) or at week 16 (r ¼ 0.36, P < 0.01) were also positively
correlated to the global histological OA score at week 35 in all
animals.
The kinetic curves of serum Coll2-1 concentration were com-
parable in the oleuropein and the control group (P ¼ 0.75). How-
ever, serum Coll2-1 kinetic curves of guinea pigs treated with rutin
(P ¼ 0.0001) or rutin þ curcumin (P ¼ 0.0015) were signiﬁcantly
lower than those of the control group [Fig. 4(A)]. The decrease was
signiﬁcant from week 16 (P < 0.05).
The Coll2-1NO2 kinetic curve in the controls was signiﬁcantly
higher than those of the other groups [P < 0.0001, Fig. 4(B)]. This
effect was signiﬁcant from week 10 (P < 0.01).
Serum Fib3-1 and Fib3-2
Fib3-1 and Fib3-2 serum levels increased over time in the
control group [P < 0.0001, Fig. 4(C) and (D)]. Fib3-1 increasedsigniﬁcantly steadily with time (2.5-fold increase in control group
at week 35 compared to week 4), while Fib3-2 reached a maximum
at week 22 (2.1-fold increase in control group compared to week 4)
and then remained stable until week 35. A strong correlation was
found at week 35 between Fib3-1 (r ¼ 0.68, P < 0.01) or Fib3-2
(r ¼ 0.85, P < 0.001) levels and the global histological OA score,
and between Fib3-2 and the global synovial histological score
(r ¼ 0.60, P < 0.05).
However, while Fib3-1 kinetic curve of the oleuropein group
was not statistically different of that of the control group (P¼ 0.52),
the kinetic curve of rutin þ curcumin group was signiﬁcantly lower
(P ¼ 0.003), and tended to be lower in the rutin group (P ¼ 0.097)
than that of the control [Fig. 4(C)].
The Fib3-2 kinetic curves varied with treatments [P ¼ 0.0003,
Fig. 4(D)]. In fact, as compared to the control group, Fib3-2
increased more slowly in oleuropein group (P ¼ 0.0064) and in
rutin þ curcumin group (P ¼ 0.0014). No signiﬁcant difference was
found between rutin and control group kinetic curves (P ¼ 0.90).
Serum ARGS
The serum levels of ARGS decreased signiﬁcantly with time
[P < 0.001, Fig. 5(A)] in all groups. No signiﬁcant difference between
kinetic curves was observed. However, at week 35, ARGS levels
were signiﬁcantly lower in the rutin and the rutin þ curcumin
groups than in the control group [P < 0.05, Fig. 5(B)].
Discussion
In this study, three phytonutrients, oleuropein and rutin alone
or a combination of rutin and curcumin, were evaluated at physi-
ological and nutritional doses for their effects on spontaneous
development of OA in the guinea pig model.
Same doses have been shown to be efﬁcient in rodents for
different health beneﬁts, e.g., bone health20,21 or atherosclerosis22,23.
Fig. 2. (A) Global OA score. (B) Cartilage surface integrity score. (C) Proteoglycans content score. (D) Cellularity score. (E) Tidemark integrity score. (F) Osteophyte score. Mean ± 95%
CI, * ¼ P < 0.05, ** ¼ P < 0.01, *** ¼ P < 0.001, one-way ANOVA with Dunnet's post-test.
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aglycon equivalent) has been reported 9.46 ± 1 mM for rutin20,
24 ± 2.3 nM for oleuropein24,25 and 1.6 ± 0.1 mM for curcumin
glucuronide (0.28 ± 0.07 mM for curcumin sulfate)26.
None of the phytonutrient supplements signiﬁcantly modiﬁed
food intake or guinea pig growth. This important ﬁnding indicates
that treatment effects were not linked to weight changes27. Tested
compounds did not induce acute toxicity on major organs like
kidney or liver (data not shown).
Supplementation with these phytonutrient treatments signif-
icantly slowing down OA development, showing a signiﬁcant
decrease of the histological OA scores compared to controls.
Looking individually at each parameter of this global score,
oleuropein and rutin reduced cartilage surface integrity and
proteoglycans content scores, but only oleuropein was efﬁcient
on decreasing osteophyte formation. In this model, other treat-
ments such as tetracyclines28, pioglitazone29, hyaluronan intra-
articular injections30 or phosphocitrate administration31 have
previously shown an improvement of this global Mankin-derived
score.
We evaluated polyphenol effects on inﬂammation bymeasuring
PGE2 in serum and by assessing synovial histological score. Only
oleuropein consumption signiﬁcantly reduced these parameters,indicating that this compound acts on both cartilage lesion and
synovium inﬂammation. Nevertheless, this remains a secondary
outcome only enlightened us on mechanisms, because this spon-
taneous animal model shows only a mild inﬂammation, like in
human OA.
We also aimed to study some OA biomarkers in this guinea pig
model, and their relevance to follow-up treatments slowing down
OA development. More precisely, we measured serum Coll2-1,
Coll2-1NO2, Fib3-1 and Fib3-2, and a neoepitope of aggrecanase
degradation of aggrecan, ARGS.
These biomarkers are all related to OA disease. Coll2-1, a peptide
located in the triple helical part of type II collagen molecule, is a
marker of collagen network degradation found at elevated levels in
the serum of knee and hip OA patients32. In this study, Coll2-1
increased early in OA development. This ﬁnding corroborates a
previous study demonstrating that Coll2-1 increase was concomi-
tant with the early type II collagen ﬁbril disruption3. Further, the
change of serum Coll2-1 levels between week 4 and 10 was corre-
lated with the ﬁnal global histological OA score at week 35. This
means that the early increase of Coll2-1 could bepredictiveof theOA
natural course. Coll2-1NO2 is the nitrated form of Coll2-1 and
correlated with c-reactive protein (CRP) in human OA and RA pa-
tients33. Fib3-1 and Fib3-2 are two speciﬁc peptides of ﬁbulin-3.
Fig. 3. (A) Global synovial histological score in each group. (B): PGE2 levels found in guinea pig sera at week 4 or week 35. Mean ± 95% CI, * ¼ P < 0.05, ** ¼ P < 0.01 and
*** ¼ P < 0.001, one-way ANOVA with Dunnet's post-test.
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compared to healthy subjects34. The antibodies used in the Fib3-1
and Fib3-2 immunoassays don't recognize the native ﬁbulin-3
indicating that Fib3-1 and Fib3-2 levels reﬂect ﬁbulin-3 degrada-
tion. This is important because ﬁbulin-3 knock-outmice develop OA
indicating that ﬁbulin-3 is important to maintain cartilage
homoeostasis. In this study, we showed for the ﬁrst time that Coll2-
1NO2, Fib3-1 and Fib3-2were correlatedwith histological global OA
score while Coll2-1NO2 and Fib3-2 also correlated with synovial
histological score. These data suggest that these markers are rele-
vantburdenofdiseasebiomarkers inguineapigOAmodel. Theymay
also be useful to evaluate efﬁcacy of intervention (e.g., nutrients)
since early decrease of these biomarkers was correlated with the
decrease of the histological OA score induced by phytonutrients. For
the ﬁrst time, we have also investigated the kinetic of ARGS, a neo-
epitope generated by aggrecanases, in the serum of guinea pig.
Serum ARGS drastically decreased between weeks 4 and 22, and
tended to increase betweenweek28 and 35. The early drop of serum
ARGS, probably reﬂects the high turnover in the growth plate of
these guineapigswhich are still in growingphaseuntil 18-week-old.
This biomarker couldbehelpful after the growingphase to followOA
course in this guinea pig model. However, additional longer exper-
iments are needed to conﬁrm and to validate this hypothesis.
Rutin alone or with curcumin early decreased Coll2-1, Coll2-
1NO2, and later ARGS, showing an anti-catabolic proﬁle of these
phytonutrients. In contrast, oleuropein decreased Coll2-1NO2
levels in parallel to the PGE2 levels and synovial score suggesting
that this compound exerts in vivo anti-inﬂammatory and anti-
oxidant effects. This observation also indicates that oleuropein
and rutin modulate different OA physiopathologic processes. This
also gives a rationale to the combined administration of oleuropein
and rutin to treat OA.
The ability of rutin to decrease the biomarkers of cartilage
degradation as well as the cartilage lesion histological score may be
related to the antioxidant properties of its metabolite quercetin.
Indeed, it was recently shown that quercetin was able to decreaseaggrecan loss from explants and IL-1-stimulated a disintegrin and
metalloproteinase with thrombospondin motif (ADAMTS-4) in
chondrocytes35.
Surprisingly, when mixing with rutin, curcumin did not shown
any additive or synergistic effect on histological or synovial scores
This could be explained by the action already provide by rutin
treatment in this study.
Oleuropein effects may be linked to oleuropein itself or to its
major metabolite, hydroxytyrosol, which is one of the most potent
oxygen radical scavenger36 and a potent activator of manganese
superoxide dismutase gene expression37. Hydroxytyrosol also has
anti-inﬂammatory properties, decreasing 5-lipooxygenase activity
and leukotriene B4 production. Oleuropein elicited protective ef-
fects on bonemass in a rat model inwhich bone loss was associated
with ovariectomy and acute inﬂammation21. It was hypothesised
that oleuropein may exert its bone-sparing effect by modulating
inﬂammation rather than acting directly on bone metabolism.
Indeed, neither oleuropein nor whole olive oil was able to affect
bone mineral density in ovariectomised rats when inﬂammation
was not induced38.
The major limitation of our study is the absence of a non-OA age
matching control group. This is important since we know that
Hartley guinea pig bone growth is prolonged until week 18. During
the ﬁrst weeks, some biomarkers serum levels are probably
confounded by growth plate remodelling associated with a high
release of neoepitopes. However, no staining of Coll2-1 was found
in the cartilage growth plate of these animals3. Furthermore,
ﬁbulin-3 fragment biomarkers lack of tissue speciﬁcity. Indeed,
ﬁbulin-3 is ubiquitous and found in a lot of tissues, thereforewe can
suspect that these biomarkers levels reﬂected more a systemic ef-
fect of the drugs, on different connective tissues. Another particu-
larity of this model is that early OA lesions appear concomitantly
with growth plate remodelling. For this reason, we have investi-
gated biomarkers levels at an early time point, before the ﬁrst type
II collagen lesions are visible3. Indeed, in this study we observed
that Coll2-1, Coll2-1NO2, Fib3-1 and Fib3-2 increased early
Fig. 4. (A) Coll2-1 (B) Coll2-1NO2 (C) Fib3-1 (D) Fib3-2 levels found in guinea pig sera. Means ± 95% CI.
Fig. 5. ARGS levels found in guinea pig sera. (A) across time (B) at week 35. Means ± 95% CI, * ¼ P < 0.05 one-way ANOVA with Dunnet's post-test.
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strengthened by comparing DunkineHartley to Strain 13 and
Bristol strain 2 guinea pigs. In these guinea pigs, OA lesions are
delayed and they could be used as comparator, even if there are not
OA free at 35 weeks2,39.
In conclusion, oleuropein and rutin induced interesting meta-
bolic and structural effects on OA cartilage and synovium sup-
porting their use in human trials. While the mixture of curcumin
and rutin did not provide additive or synergistic effects compared
to rutin alone on histological score, the combination of rutin and
oleuropein might be worth investigating further due to their
complementary mechanisms of action, protecting against pro-
inﬂammatory and catabolic processes involved in development
of OA. Coll2-1NO2 could be a good biomarker to monitor the
protective effects of these compounds in guinea pig or human
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